Pathstone Holdings LLC Purchases 210 Shares of Chemed Co. (NYSE:CHE)

Pathstone Holdings LLC grew its position in Chemed Co. (NYSE:CHE) by 6.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,694 shares of the company’s stock after acquiring an additional 210 shares during the quarter. Pathstone Holdings LLC’s holdings in Chemed were worth $2,220,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Thrivent Financial for Lutherans boosted its holdings in shares of Chemed by 300.3% in the 2nd quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock worth $63,249,000 after purchasing an additional 87,449 shares during the period. International Assets Investment Management LLC purchased a new position in shares of Chemed in the 3rd quarter worth approximately $437,150,000. Impax Asset Management Group plc boosted its holdings in shares of Chemed by 19.5% in the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after purchasing an additional 51,974 shares during the period. Epoch Investment Partners Inc. boosted its holdings in shares of Chemed by 22.1% in the 2nd quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company’s stock worth $121,068,000 after purchasing an additional 40,358 shares during the period. Finally, DekaBank Deutsche Girozentrale boosted its holdings in Chemed by 34.5% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 154,579 shares of the company’s stock valued at $98,516,000 after acquiring an additional 39,633 shares during the period. Institutional investors own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. StockNews.com cut Chemed from a “buy” rating to a “hold” rating in a report on Friday, November 22nd. Royal Bank of Canada dropped their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th.

Chemed Stock Up 0.3 %

Shares of NYSE CHE opened at $573.57 on Wednesday. The business has a fifty day simple moving average of $578.95 and a two-hundred day simple moving average of $564.99. The firm has a market cap of $8.63 billion, a PE ratio of 28.80, a price-to-earnings-growth ratio of 2.42 and a beta of 0.46. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm earned $5.32 earnings per share. On average, research analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio (DPR) is presently 10.11%.

Insider Buying and Selling at Chemed

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the transaction, the executive vice president now directly owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. The trade was a 21.90 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,113 shares of company stock valued at $3,557,445 in the last ninety days. Corporate insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.